Novo-Nordisk A/S SPONS ADR

Novo Nordisk A/S, a healthcare company based in Bagsværd, Denmark, researches, develops, and markets pharmaceuticals. The company was founded in 1923. Novo Nordisk operates internationally through its worldwide locations. The company operates through two segments: the Diabetes and Obesity segment provides products such as insulin, and the Biopharmaceuticals segment focuses on products such as growth disorder and hormone replacement therapies. The company is currently collaborating with Lund University regarding Parkinson’s disease research. Novo Nordisk is listed on the NYSE under the NVO stock ticker. Add this instrument to your eToro watchlist to receive updates and news on the NVO share price.